About Antonius Schuh
Antonius Schuh is an executive officer and director at selectIon.
Antonius Schuh reports to the SEC as a director, officer or major shareholder of 3 public companies: Cardiff Oncology (CRDF), Precipio (PRPO) and Sorrento Therapeutics (SRNEQ).
Antonius Schuh first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Antonius Schuh in the role, so the role may have started earlier or lasted longer.
CI
Cardiff Oncology, Inc.
CEO and director
2012 – 2016 · Public company (CRDF)
PI
Precipio, Inc.
Director
2009 – 2014 · Public company (PRPO)
SI
Sorrento Therapeutics, Inc.
Chairman and CEO
2009 – 2010 · Public company (SRNEQ)
Key Colleagues at Startups
The people Antonius Schuh works with at each company, as listed on that company's latest Form D.
selectIon, Inc. · Form D, Sep 15, 2025
CG
Cam Gallagher
Director
MF
Michael Foster
Director
DS
Don Scifres
Director
SZ
Stephen Zaniboni
Chief Financial Officer
MW
Mark Wiggins
Director